Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure

This publication has 26 references indexed in Scilit:

• Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease
  Journal of the American College of Cardiology, 2001
• Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
  Circulation, 2000
• Spironolactone Increases Nitric Oxide Bioactivity, Improves Endothelial Vasodilator Dysfunction, and Suppresses Vascular Angiotensin I/Angiotensin II Conversion in Patients With Chronic Heart Failure
  Circulation, 2000
• How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
  Heart, 1999
• Measuring Forearm Blood Flow and Interpreting the Responses to Drugs and Mediators
  Hypertension, 1995
• The Emerging Concept of Vascular Remodeling
  New England Journal of Medicine, 1994
• Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.
  Circulation Research, 1991
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
  Circulation, 1990
• Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats.
  Hypertension, 1986
• Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.
  Circulation, 1984